These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1782072)

  • 1. Parathyroid hormone-related protein(50-69) and response to pamidronate therapy for tumour-induced hypercalcaemia.
    Dodwell DJ; Abbas SK; Morton AR; Howell A
    Eur J Cancer; 1991; 27(12):1629-33. PubMed ID: 1782072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia.
    Gurney H; Grill V; Martin TJ
    Lancet; 1993 Jun; 341(8861):1611-3. PubMed ID: 8099988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein.
    Walls J; Ratcliffe WA; Howell A; Bundred NJ
    Br J Cancer; 1994 Jul; 70(1):169-72. PubMed ID: 8018531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of tumour-induced hypercalcaemia with the bisphosphonate pamidronate: dose-response relationship and influence of tumour type.
    Body JJ; Dumon JC
    Ann Oncol; 1994 Apr; 5(4):359-63. PubMed ID: 8075034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
    Fraser WD; Logue FC; Gallacher SJ; O'Reilly DS; Beastall GH; Ralston SH; Boyle IT
    Bone Miner; 1991 Feb; 12(2):113-21. PubMed ID: 1849762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of tumour-induced hypercalcaemia in advanced breast cancer patients with three different doses of disodium pamidronate adapted to the initial level of calcaemia.
    Nesković-Konstantinović Z; Mitrović L; Petrović J; Stamatović L; Ristović Z
    Support Care Cancer; 1995 Nov; 3(6):422-4. PubMed ID: 8564348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
    Grill V; Murray RM; Ho PW; Santamaria JD; Pitt P; Potts C; Jerums G; Martin TJ
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1468-70. PubMed ID: 1592895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased efficacy of bisphosphonates for recurrences of tumor-induced hypercalcemia.
    Body JJ; Louviaux I; Dumon JC
    Support Care Cancer; 2000 Sep; 8(5):398-404. PubMed ID: 10975689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate.
    Wimalawansa SJ
    Cancer; 1994 Apr; 73(8):2223-30. PubMed ID: 8156530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of pamidronate in PTHrP associated hypercalcaemia in infancy.
    Buckmaster A; Rodda C; Cowell CT; Ogle G; Dorney S
    J Pediatr Endocrinol Metab; 1997; 10(3):301-4. PubMed ID: 9388823
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of chemotherapy on hypercalcemia in breast and lung cancer patients.
    Hassan BA; Yusoff ZB; Hassali MA; Othman SB; Weiderpass E
    Asian Pac J Cancer Prev; 2012; 13(9):4373-8. PubMed ID: 23167346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate.
    Newrick PG; Braatvedt GD; Webb AJ; Sheffield E; Corrall RJ
    Postgrad Med J; 1994 Mar; 70(821):231-2. PubMed ID: 8183761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pamidronate treatment in patients with tumor-associated hypercalcemia: pharmacological effects and pharmacokinetics.
    Oiso Y; Tomita A; Hasegawa H; Ariyoshi Y; Niinomi M; Yamamoto M; Takano T; Sakiyama N
    Endocr J; 1994 Dec; 41(6):655-61. PubMed ID: 7704089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy.
    Blind E; Raue F; Götzmann J; Schmidt-Gayk H; Kohl B; Ziegler R
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):290-7. PubMed ID: 1424212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia].
    Blind E; Raue F; Meinel T; Pecherstorfer M; Räth U; Schmidt-Gayk H; Kohl B; Ziegler R
    Dtsch Med Wochenschr; 1993 Mar; 118(10):330-5. PubMed ID: 8453901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating PTHrP concentrations in tumor-induced hypercalcemia: influence on the response to bisphosphonate and changes after therapy.
    Body JJ; Dumon JC; Thirion M; Cleeren A
    J Bone Miner Res; 1993 Jun; 8(6):701-6. PubMed ID: 8328312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD).
    Ling PJ; A'Hern RP; Hardy JR
    Br J Cancer; 1995 Jul; 72(1):206-9. PubMed ID: 7599053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.
    Vinholes J; Guo CY; Purohit OP; Eastell R; Coleman RE
    J Clin Oncol; 1997 Jan; 15(1):131-8. PubMed ID: 8996134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone related protein and hypercalcaemia in breast cancer.
    Bundred NJ; Ratcliffe WA; Walker RA; Coley S; Morrison JM; Ratcliffe JG
    BMJ; 1991 Dec; 303(6816):1506-9. PubMed ID: 1782489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.